StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
60
This year
1
Publishing Date
2024 - 01 - 16
1
2023 - 12 - 23
1
2023 - 12 - 21
1
2023 - 12 - 05
1
2023 - 11 - 23
1
2023 - 11 - 22
1
2023 - 11 - 15
1
2023 - 11 - 14
1
2023 - 10 - 18
1
2023 - 08 - 21
1
2023 - 07 - 26
1
2023 - 05 - 29
1
2023 - 05 - 19
1
2023 - 03 - 22
2
2023 - 03 - 21
1
2023 - 03 - 13
3
2023 - 03 - 03
1
2023 - 02 - 22
1
2023 - 01 - 10
1
2023 - 01 - 09
1
2023 - 01 - 04
1
2022 - 12 - 21
1
2022 - 12 - 06
1
2022 - 11 - 17
1
2022 - 10 - 19
1
2022 - 10 - 06
2
2022 - 09 - 30
1
2022 - 09 - 28
1
2022 - 09 - 26
1
2022 - 08 - 15
1
2022 - 06 - 20
1
2022 - 04 - 13
1
2021 - 12 - 06
1
2021 - 11 - 08
1
2021 - 10 - 07
1
2021 - 10 - 06
1
2021 - 09 - 27
1
2021 - 09 - 09
1
2021 - 08 - 11
1
2021 - 08 - 06
1
2021 - 07 - 29
2
2021 - 07 - 28
1
2021 - 07 - 20
1
2021 - 06 - 29
1
2021 - 06 - 28
1
2021 - 06 - 21
1
2021 - 06 - 18
2
2021 - 06 - 14
1
2021 - 05 - 10
2
2021 - 04 - 23
1
2021 - 03 - 30
1
2021 - 03 - 10
1
2021 - 01 - 22
1
Sector
Electronic technology
1
Health technology
60
Manufacturing
2
Tags
Acquisition
87
Alliances
89
America
64
Antibody
65
Approval
98
Biopharma
108
Biotech
87
Biotechnology
122
Business
82
Cancer
217
Children
68
Clinical-trials-phase-ii
51
Clinical-trials-phase-iii
80
Collaboration
102
Companies
59
Conference
58
Covid
128
Covid-19
111
Diabetes
60
Disease
179
Drug
244
Dupixent
118
Earnings
97
Europe
92
Events
61
Fda
237
Financial
164
Financial results
72
Genetown
74
Global
356
Growing
56
Growth
325
Health
71
Insulin
54
Iot
56
Market
720
Money
70
N/a
2820
News
129
People
224
Pharm-country
55
Pharma
193
Pharmaceutical
143
Positive
103
Potential
67
Regulatory
58
Report
312
Research
266
Results
367
Sanofi
201
Spac
62
Study
87
Technology
68
Therapeutics
344
Therapy
114
Treatment
281
Trial
166
Update
92
Vaccine
258
Year
61
Entities
Abbott laboratories
8
Alnylam pharmaceuticals, inc.
1
Amgen inc.
3
Arko corp - class a
1
Astrazeneca plc
11
Baxter international inc.
2
Becton, dickinson and company
6
Bio-rad laboratories, inc.
3
Biotelemetry, inc.
1
Boston scientific corporation
1
Crispr therapeutics ag
1
Danaher corporation
3
Dexcom, inc.
5
Eli lilly and company
11
Entera bio ltd.
1
Glaxosmithkline plc
7
Incyte corporation
2
Insulet corporation
4
Johnson & johnson
7
Mannkind corporation
2
Medtronic plc
7
Nemaura medical inc.
1
Novartis ag
9
Novo nordisk a/s
8
Pfizer, inc.
1
Provention bio, inc.
5
Reata pharmaceuticals, inc.
1
Regeneron pharmaceuticals, inc.
1
Retractable technologies, inc.
1
Sanofi
60
Senseonics holdings, inc.
1
Takeda pharmaceutical company limited
1
Tandem diabetes care, inc.
3
Terumo corp
2
Trinity biotech plc
3
Vertex pharmaceuticals incorporated
1
Viatris inc.
1
Symbols
ABT
31
AKRO
3
ALT
3
AMGN
3
APLT
3
ATRX
4
AZN
16
AZNCF
10
BAX
6
BDX
15
BMEA
27
BTTX
11
CELZ
4
CRSP
4
DRIO
4
DXCM
25
EMBC
5
EVO
4
EVOTF
7
FNCTF
7
GLAXF
5
GNPX
6
GSK
7
INCY
6
JNJ
17
LLY
57
LXRX
11
MDT
26
MNKD
12
MNOV
4
MTCR
4
NMRD
9
NVO
34
NVRO
9
NVS
18
NVSEF
15
OCUP
4
ORMP
9
PBLA
4
PFE
4
PODD
20
PRVB
15
RGNX
4
RNLX
6
RTNXF
5
SABS
7
SENS
13
SEOVF
14
SNY
60
SNYNF
41
TNDM
34
TRIB
4
TRUMF
7
TRUMY
7
UL
5
UNLYF
4
VRTX
11
VTVT
11
ZEAL
7
ZVSA
4
Exchanges
Amex
2
Nasdaq
60
Nyse
30
Crawled Date
2024 - 01 - 16
1
2023 - 12 - 23
1
2023 - 12 - 22
1
2023 - 12 - 05
1
2023 - 11 - 23
1
2023 - 11 - 22
1
2023 - 11 - 15
1
2023 - 11 - 14
1
2023 - 10 - 18
1
2023 - 08 - 21
1
2023 - 07 - 26
1
2023 - 05 - 29
1
2023 - 05 - 19
1
2023 - 03 - 23
1
2023 - 03 - 22
1
2023 - 03 - 21
1
2023 - 03 - 13
3
2023 - 03 - 03
1
2023 - 02 - 23
1
2023 - 01 - 10
1
2023 - 01 - 09
1
2023 - 01 - 04
1
2022 - 12 - 21
1
2022 - 12 - 06
1
2022 - 11 - 17
1
2022 - 10 - 19
1
2022 - 10 - 06
2
2022 - 09 - 30
1
2022 - 09 - 28
1
2022 - 09 - 26
1
2022 - 08 - 15
1
2022 - 06 - 20
1
2022 - 04 - 13
1
2021 - 12 - 06
1
2021 - 11 - 08
1
2021 - 10 - 07
1
2021 - 10 - 06
1
2021 - 09 - 27
1
2021 - 09 - 09
1
2021 - 08 - 11
1
2021 - 08 - 06
1
2021 - 07 - 29
2
2021 - 07 - 28
1
2021 - 07 - 20
1
2021 - 06 - 29
1
2021 - 06 - 28
1
2021 - 06 - 21
1
2021 - 06 - 18
2
2021 - 06 - 14
1
2021 - 05 - 10
2
2021 - 04 - 23
1
2021 - 03 - 31
1
2021 - 03 - 10
1
2021 - 01 - 22
1
Crawled Time
00:00
5
04:00
3
04:20
1
05:00
2
07:00
4
09:00
2
11:00
2
12:00
4
12:30
1
13:20
1
14:00
3
14:01
1
14:20
1
15:00
4
15:15
2
16:00
6
17:00
5
18:00
2
19:00
2
19:07
1
20:00
3
22:00
3
23:00
2
Source
spacfeed.com
1
www.biospace.com
12
www.clarivate.com
1
www.globenewswire.com
2
www.prnewswire.com
44
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Diabetes
symbols :
SNY
save search
International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries
Published:
2024-01-16
(Crawled : 07:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-11.08%
|
O:
-2.03%
H:
0.05%
C:
0.05%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-10.14%
|
O:
-1.34%
H:
0.0%
C:
0.0%
health
international
global
response
diabetes
sanofi
NFL Stars Support JDRF and Champion Type 1 Diabetes Awareness through the "My Cause My Cleats" Campaign
Published:
2023-12-23
(Crawled : 04:20)
- prnewswire.com
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
Email alert
Add to watchlist
diabetes
Digital Diabetes Management Market Forecast Report 2023-2030, Featuring Key Players Medtronic, Abbott, Ascensia Diabetes Care, F. Hoffmann-La Roche, Bayer, LifeScan & Insulet
Published:
2023-12-21
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-1.63%
|
O:
3.66%
H:
0.0%
C:
-0.12%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-3.43%
|
O:
1.03%
H:
0.0%
C:
0.0%
PODD
|
$167.17
-0.06%
130K
|
Health Technology
|
-23.61%
|
O:
-0.14%
H:
0.27%
C:
-1.13%
DXCM
|
$136.16
1.61%
1M
|
Health Technology
|
9.12%
|
O:
-0.34%
H:
0.19%
C:
-0.17%
management
report
diabetes
market
Diabetes Management Apps Market to Record an Exponential CAGR of 24.4% by 2031 - Exclusive Report by InsightAce Analytic
Published:
2023-12-05
(Crawled : 12:30)
- prnewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
0.37%
|
O:
0.27%
H:
0.12%
C:
0.12%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
0.59%
|
O:
-0.5%
H:
0.0%
C:
0.0%
BEAT
|
$2.045
0.25%
4.4K
|
Health Technology
|
38.78%
|
O:
0.0%
H:
2.04%
C:
-1.36%
management
report
diabetes
market
Global and Country Cell Therapies for Type 1 Diabetes Research Report 2023: Epidemiology, Pipeline and Target Market Assessment Analysis and Forecast to 2030
Published:
2023-11-23
(Crawled : 17:00)
- prnewswire.com
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
Email alert
Add to watchlist
CRSP
|
News
M
|
$56.02
-0.69%
390K
|
Health Technology
|
Email alert
Add to watchlist
report
pipeline
cell
research
global
diabetes
market
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Type 2 Diabetes in Diabetes Care
Published:
2023-11-22
(Crawled : 05:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
1.31%
|
O:
-0.74%
H:
0.71%
C:
0.71%
LLY
|
News
|
$731.81
-1.86%
1M
|
Health Technology
|
23.58%
|
O:
-0.44%
H:
0.63%
C:
-0.05%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
1.01%
|
O:
-0.34%
H:
0.0%
C:
0.0%
ibi362
publication
care
chinese
diabetes
results
phase 2
Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published:
2023-11-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
6.69%
|
O:
3.37%
H:
1.29%
C:
1.29%
NVO
|
News
|
$125.705
-2.28%
1.3M
|
Health Technology
|
33.4%
|
O:
2.62%
H:
0.67%
C:
0.58%
LLY
|
News
|
$731.81
-1.86%
1M
|
Health Technology
|
21.05%
|
O:
-3.12%
H:
0.61%
C:
-0.46%
VRTX
|
$401.7
-0.79%
280K
|
Health Technology
|
15.91%
|
O:
0.4%
H:
0.38%
C:
-2.2%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
3.75%
|
O:
1.54%
H:
0.0%
C:
0.0%
companies
diabetes
study
market
More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds
Published:
2023-11-14
(Crawled : 00:00)
- prnewswire.com
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
3.7%
|
O:
0.68%
H:
0.0%
C:
0.0%
international
diabetes
study
Press Release: TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The NEJM
Published:
2023-10-18
(Crawled : 09:00)
- globenewswire.com
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-13.51%
|
O:
-1.23%
H:
0.0%
C:
0.0%
tzield
children
diabetes
potential
Global Diabetes Drugs Market to Reach $106.65 Billion by 2028: Rising Prevalence of Diabetes Fuels Growth
Published:
2023-08-21
(Crawled : 16:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-12.46%
|
O:
-0.02%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
1.5K
|
Health Technology
|
3.14%
|
O:
0.16%
H:
0.51%
C:
0.51%
NVS
|
News
|
$97.515
0.24%
820K
|
Health Technology
|
-2.14%
|
O:
1.5%
H:
0.52%
C:
0.43%
JNJ
|
News
|
$148.22
-0.9%
3.3M
|
Health Technology
|
-13.67%
|
O:
-2.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-11.39%
|
O:
1.17%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.065
0.3%
3.2M
|
Health Technology
|
3.49%
|
O:
0.76%
H:
0.23%
C:
-0.14%
reach
global
diabetes
growth
market
UK Probes Weight Loss, Diabetes Drugs for Suicidal Ideation and Self-Harm Risk
Published:
2023-07-26
(Crawled : 22:00)
- biospace.com/
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-12.7%
|
O:
-1.57%
H:
0.0%
C:
0.0%
risk
diabetes
Blood Glucose Monitoring Devices Market to grow by USD 7,488.81 million during 2023-2027; The rising global burden of diabetes to drive the market growth - Technavio
Published:
2023-05-29
(Crawled : 17:00)
- prnewswire.com
ABT
|
News
|
$106.78
-0.75%
2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
Email alert
Add to watchlist
MDT
|
$80.71
-0.71%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
Email alert
Add to watchlist
blood
global
diabetes
growth
market
Diabetes Management Devices Market size to grow by USD 10.9 billion from 2022 to 2027, Growing focus on the artificial pancreas to be a major trend - Technavio
Published:
2023-05-19
(Crawled : 20:00)
- prnewswire.com
NMRD
|
$0.06
120K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$106.78
-0.75%
2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
Email alert
Add to watchlist
MDT
|
$80.71
-0.71%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
management
pancreas
growing
diabetes
market
Diabetes Drugs Global Market Report 2022: Featuring AstraZeneca, Eli Lilly, GlaxoSmithKline, Merck, Pfizer & More
Published:
2023-03-22
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
10.74%
|
O:
1.11%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-3.5%
|
O:
5.54%
H:
0.96%
C:
0.96%
AZNCF
|
News
|
$140.3
1.5K
|
Health Technology
|
3.5%
|
O:
-1.81%
H:
0.51%
C:
0.51%
JNJ
|
News
|
$148.22
-0.9%
3.3M
|
Health Technology
|
-0.92%
|
O:
0.08%
H:
0.34%
C:
-0.03%
GSK
|
News
|
$40.755
-1.18%
660K
|
Health Technology
|
18.17%
|
O:
1.69%
H:
0.11%
C:
-0.76%
LLY
|
News
|
$731.81
-1.86%
1M
|
Health Technology
|
123.3%
|
O:
-0.02%
H:
1.34%
C:
0.53%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-3.61%
|
O:
6.53%
H:
0.56%
C:
-0.54%
AZN
|
News
|
$71.065
0.3%
3.2M
|
Health Technology
|
6.43%
|
O:
1.56%
H:
0.34%
C:
-0.52%
report
global
diabetes
market
Global Diabetes Diagnostics Business Report 2023-2030: Quality Products at Low Prices - The Mantra for Success in the Marketplace
Published:
2023-03-22
(Crawled : 18:00)
- prnewswire.com
TRUMF
|
$16.608
5.6K
|
Health Technology
|
-37.82%
|
O:
1.45%
H:
1.35%
C:
-0.11%
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-3.5%
|
O:
0.0%
H:
0.0%
C:
0.0%
TRUMY
|
$17.05
47K
|
Manufacturing
|
-36.59%
|
O:
0.78%
H:
1.35%
C:
0.3%
MDT
|
$80.71
-0.71%
1.9M
|
Health Technology
|
0.07%
|
O:
0.27%
H:
0.64%
C:
-1.85%
DHR
|
$249.35
-1.49%
1.1M
|
Health Technology
|
1.9%
|
O:
0.4%
H:
1.37%
C:
-1.23%
BIO
|
$278.46
-2.39%
51K
|
Health Technology
|
-40.6%
|
O:
-0.05%
H:
0.6%
C:
-2.88%
BDX
|
$234.225
-0.06%
330K
|
Health Technology
|
-2.45%
|
O:
0.28%
H:
1.3%
C:
-0.83%
TRIB
|
$1.83
530
|
Health Technology
|
98.89%
|
O:
-0.01%
H:
3.26%
C:
1.64%
TNDM
|
$34.65
-0.92%
220K
|
Health Technology
|
-20.0%
|
O:
-0.23%
H:
1.01%
C:
-4.93%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-3.66%
|
O:
-0.06%
H:
0.0%
C:
0.0%
DXCM
|
$136.16
1.61%
1M
|
Health Technology
|
12.62%
|
O:
-0.04%
H:
0.26%
C:
-3.3%
success
report
business
global
diagnostics
diabetes
Enable Biosciences Announces Relaunch of Website for Early Detection of Type 1 Diabetes
Published:
2023-03-21
(Crawled : 14:20)
- biospace.com/
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-1.82%
|
O:
1.74%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-1.61%
|
O:
2.13%
H:
0.0%
C:
0.0%
diabetes
Sanofi Bolsters Diabetes Position with $2.9B Provention Buyout
Published:
2023-03-13
(Crawled : 14:00)
- biospace.com/
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-1.48%
|
O:
-0.81%
H:
0.0%
C:
0.0%
diabetes
sanofi
Press Release : Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D) – Marketscreener.com
Published:
2023-03-13
(Crawled : 07:00)
- spacfeed.com
ARKO
A
|
$4.325
-2.59%
96K
|
|
-48.49%
|
O:
-1.39%
H:
2.47%
C:
-0.47%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-1.48%
|
O:
-0.81%
H:
0.0%
C:
0.0%
treatment
acquire
diabetes
sanofi
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)
Published:
2023-03-13
(Crawled : 07:00)
- globenewswire.com
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-1.48%
|
O:
-0.81%
H:
0.0%
C:
0.0%
PRVB
|
$24.98
0.08%
9.1M
|
Health Technology
|
253.82%
|
O:
241.08%
H:
0.62%
C:
0.08%
treatment
acquire
diabetes
sanofi
Type 2 diabetes market size to increase by USD 39.37 billion between 2022 and 2027; Growth driven by increasing prevalence of diabetes - Technavio
Published:
2023-03-03
(Crawled : 16:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
13.77%
|
O:
0.09%
H:
1.57%
C:
1.51%
AZNCF
|
News
|
$140.3
1.5K
|
Health Technology
|
6.64%
|
O:
-1.0%
H:
0.73%
C:
-0.19%
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
39.53%
|
O:
0.99%
H:
0.0%
C:
-0.1%
NVS
|
News
|
$97.515
0.24%
820K
|
Health Technology
|
16.14%
|
O:
-0.55%
H:
0.27%
C:
0.04%
GSK
|
News
|
$40.755
-1.18%
660K
|
Health Technology
|
19.26%
|
O:
-0.38%
H:
0.65%
C:
0.61%
BAX
|
$40.84
-0.44%
530K
|
Health Technology
|
3.53%
|
O:
1.11%
H:
0.67%
C:
-0.3%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-1.2%
|
O:
-0.46%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.065
0.3%
3.2M
|
Health Technology
|
8.83%
|
O:
-0.61%
H:
0.8%
C:
0.77%
AMGN
|
News
|
$274.065
0.19%
570K
|
Health Technology
|
16.53%
|
O:
0.11%
H:
0.38%
C:
-0.08%
diabetes
growth
market
← Previous
1
2
3
Next →
Gainers vs Losers
55%
45%
Top 10 Gainers
CSSE
4
|
$0.3499
129.74%
150M
|
Consumer Services
CZOO
|
$11.04
121.24%
9.6M
|
BOF
|
$2.05
75.21%
78M
|
AMST
|
$3.2
60.0%
63M
|
Technology Services
LICN
|
$0.8592
53.43%
13M
|
WIMI
|
$1.05
44.75%
13M
|
Technology Services
TROO
|
$1.51
38.53%
5.6M
|
Manufacturing
MULN
|
News
|
$3.7
35.53%
6.4M
|
Information
RILY
|
$27.91
28.5%
8.9M
|
Finance
WHLM
|
$6.43
26.58%
580K
|
Commercial Services
Your saved searches
Save your searches and get alerts when important news are released.